Equillium to Participate in Upcoming Investor Conferences
Equillium, Inc. (EQ)
Last equillium, inc. earnings: 3/26 04:07 pm
Check Earnings Report
Company Research
Source: Business Wire
LA JOLLA, Calif.--(BUSINESS WIRE)--Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders, today announced that it will be participating in the Leerink Partners Therapeutic Forum: I&I and Metabolism, as well as the JonesTrading Healthcare Seaside Summit.The Leerink Partners event, taking place in Boston, Massachusetts, July 9 & 10, includes one-on-one investor meetings and panel presentations by key opinion leaders addressing a variety of inflammation and immunology indications. The JonesTrading Healthcare Seaside Summit will include a corporate presentation highlighting the company’s clinical programs and partnership with Ono Pharmaceutical, as well as one-on-one investor meetings.Conference: JonesTrading Healthcare Seaside SummitLocation: Alila Marea Beach Resort, Encinitas CaliforniaDate: Monday, July 15Time: 9:30 am Pacific Time | 12:30 pm Eastern TimeWebcast access wil
Show less
Read more
Impact Snapshot
Event Time:
EQ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EQ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EQ alerts
High impacting Equillium, Inc. news events
Weekly update
A roundup of the hottest topics
EQ
News
- Equillium Announces Abstract Accepted for Poster Presentation at the Society for Immunotherapy of CancerBusiness Wire
- Graft versus Host Disease Market to Increase at a CAGR of 9.9% During the Study Period (2020–2034) | DelveInsight [Yahoo! Finance]Yahoo! Finance
- Equillium collaborates with Vivtex for oral formulation of autoimmune therapy [Yahoo! Finance]Yahoo! Finance
- Equillium to Present at the Stifel Virtual Inflammation & Immunology SummitBusiness Wire
- Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)Business Wire
EQ
Earnings
- 5/9/24 - Beat
EQ
Analyst Actions
- 8/19/24 - HC Wainwright
EQ
Sec Filings
- 10/29/24 - Form 4
- 9/27/24 - Form 4
- 9/17/24 - Form 4
- EQ's page on the SEC website